Breast cancer as a heterogeneous disease could be divided into different molecular subtypes including Luminal A, Luminal B, Basal, HER2+, and HER2− based on the expression of estrogen receptor (ER), progesterone receptor (PR), and HER2 (Figure S3) [37–39]. Here, ERBB2 is linked to breast cancer.